🔎 Trials Near Me

Home › Atrial Fibrillation › Virginia › Arlington

Atrial Fibrillation clinical trials in Arlington, VA

5 studies for Atrial Fibrillation are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

RecruitingPhase 3
  • Conquest Research, Vienna · 9 mi away
  • Carient Heart & Vascular, Manassas · 22 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07626411

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

RecruitingPhase 3
  • Conquest Research, Vienna · 9 mi away
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07430956

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Recruiting
  • Inova Fairfax Hospital, Falls Church · 4 mi away
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07298473

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

RecruitingPhase 3
  • Anthos Investigative Site 1018, Falls Church · 4 mi away
  • Anthos Investigative Site 9949, Vienna · 9 mi away
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

RecruitingPhase 3
  • Inova Fairfax Hospital, Falls Church · 4 mi away
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046

About Atrial Fibrillation

Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.

More about Atrial Fibrillation on MedlinePlus

Atrial Fibrillation trials in other cities

Other studies in Arlington

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.